Search Results - "Neesse, A"

P-MAPS Pancreatitis - Microbiome As Predictor of Severity by Ammer-Herrmenau, Christoph, Neesse, A.

Get full text

Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer by Hessmann, E, Patzak, M S, Klein, L, Chen, N, Kari, V, Ramu, I, Bapiro, T E, Frese, K K, Gopinathan, A, Richards, F M, Jodrell, D I, Verbeke, C, Li, X, Heuchel, R, Löhr, J M, Johnsen, S A, Gress, T M, Ellenrieder, V, Neesse, A

“…Desmoplasia and hypovascularity are thought to impede drug delivery in pancreatic ductal adenocarcinoma (PDAC). However, stromal depletion approaches have…”
Get more information

Stromal biology and therapy in pancreatic cancer by Neesse, Albrecht, Michl, Patrick, Frese, Kristopher K, Feig, Christine, Cook, Natalie, Jacobetz, Mike A, Lolkema, Martijn P, Buchholz, Malte, Olive, Kenneth P, Gress, Thomas M, Tuveson, David A

“…Pancreatic ductal adenocarcinoma (PDA) is an almost uniformly lethal disease. One explanation for the devastating prognosis is the failure of many…”
Get more information

Autoimmune pancreatitis—New evidence for clinical management strategies by Ammer‐Herrmenau, C., Hamm, J., Neesse, A.

“…According to International Consensus Diagnostic Criteria, AIP is categorized into type 1, type 2, and not otherwise specified (NOS). Besides the association…”
Get full text

Sonographic patterns of renal lymphoma in B-mode imaging and in contrast-enhanced ultrasound (CEUS)—A retrospective evaluation by Trenker, C, Neesse, A, Görg, C

“…Abstract Introduction Retrospective analysis of sonographic patterns of renal lymphoma in B-mode imaging and contrast-enhanced ultrasound (CEUS)…”
Get full text

Claudin-4 as therapeutic target in cancer by Neesse, A., Griesmann, H., Gress, T.M., Michl, P.

“…► Claudin-4 is an integral constituent of tight junctions. ► Claudin-4 is differentially expressed in a variety of epithelial malignancies. ► Claudin-4…”
Get full text

Study protocol P-MAPS: microbiome as predictor of severity in acute pancreatitis—a prospective multicentre translational study by Ammer-Herrmenau, C, Asendorf, T, Beyer, G, Buchholz, S. M, Cameron, S, Damm, M, Frost, F, Henker, R, Jaster, R, Phillip, V, Placzek, M, Ratei, C, Sirtl, S, van den Berg, T, Weingarten, M. J, Woitalla, J, Mayerle, J, Ellenrieder, V, Neesse, A

“…Abstract Background Acute pancreatitis (AP) is an inflammatory disorder that causes a considerable economic health burden. While the overall mortality is low,…”
Get full text

Scheduling nab-paclitaxel combined with gemcitabine as first-line treatment for metastatic pancreatic adenocarcinoma by Corrie, P. G., Qian, W., Basu, B., Valle, J. W., Falk, S., lwuji, C., Wasan, H., Palmer, D., Scott-Brown, M., Wadsley, J., Arif, S., Bridgewater, J., Propper, D., Gillmore, R., Gopinathan, A., Skells, R., Bundi, P., Brais, R., Dalchau, K., Bax, L., Chhabra, A., Machin, A., Dayim, A., McAdam, K., Cummins, S., Wall, L., Ellis, R., Anthoney, A., Evans, J., Ma, Y. T., Isherwood, C., Neesse, A., Tuveson, D., Jodrell, D. I.

“…Background Nab-paclitaxel plus gemcitabine (nabP+gemcitabine) offers modest survival gains for patients with metastatic pancreatic ductal adenocarcinoma…”
Get full text

CUX1 modulates polarization of tumor-associated macrophages by antagonizing NF-κB signaling by Kühnemuth, B, Mühlberg, L, Schipper, M, Griesmann, H, Neesse, A, Milosevic, N, Wissniowski, T, Buchholz, M, Gress, T M, Michl, P

“…Many solid cancers including pancreatic ductal adenocarcinoma (PDAC) are characterized by an extensive stromal reaction that is accompanied by infiltrating…”
Get full text

CUX1: target of Akt signalling and mediator of resistance to apoptosis in pancreatic cancer by Ripka, S, Neesse, A, Riedel, J, Bug, E, Aigner, A, Poulsom, R, Fulda, S, Neoptolemos, J, Greenhalf, W, Barth, P, Gress, T M, Michl, P

“…The transcription factor CUX1 is known as a regulator of cell differentiation and cell cycle progression. Previously, CUX1 was identified as a modulator of…”
Get more information

Detection of peripheral embolic consolidations using contrast‐enhanced ultrasonography in patients with no evidence of pulmonary embolism on computed tomography: A pilot study by Trenker, C., Apitzsch, J.C., Pastor, S., Bartelt, S., Neesse, A., Goerg, C.

“…ABSTRACT Aim To investigate the value of B‐mode imaging and contrast‐enhanced ultrasonography (CEUS) in patients with clinically suspected pulmonary embolism…”
Get full text

Gemcitabine diphosphate choline is a major metabolite linked to the Kennedy pathway in pancreatic cancer models in vivo by Bapiro, T E, Frese, K K, Courtin, A, Bramhall, J L, Madhu, B, Cook, N, Neesse, A, Griffiths, J R, Tuveson, D A, Jodrell, D I, Richards, F M

“…Background: The modest benefits of gemcitabine (dFdC) therapy in patients with pancreatic ductal adenocarcinoma (PDAC) are well documented, with drug delivery…”
Get full text

Pancreatitis - Microbiome As Predictor of Severity (P-MAPS): A prospective international multicentre translational study by Ammer-Herrmenau, C., Antweiler, K.L., Asendorf, T., Buchholz, S., Cameron, S., Damm, M., Frost, F., Gomes, A., Henker, R., Hoffmeister, A., Meinhardt, C., Nawacki, L., Panyko, A., Phillip, V., Rasch, S., Rinjia, E., Rebollo, M. L. Ruiz, Sirtl, S., Weingarten, M., Sandru, V., Woitalla, J., Ellenrieder, V., Neesse, A.

Get full text

Spontaneous and Traumatic Splenic Rupture: Retrospective Clinical, B-Mode and CEUS Analysis in 62 Patients by Rosling, M., Trenker, C., Neesse, A., Görg, C.

“…Abstract Introduction Both B-mode ultrasound and contrast-enhanced ultrasound (CEUS) are well established procedures when diagnosing traumatic splenic ruptures…”
Get full text

nab-Paclitaxel: novel clinical and experimental evidence in pancreatic cancer by Neesse, A, Michl, P, Tuveson, D A, Ellenrieder, V

“…The past few decades have seen virtually no treatment advances for patients with metastatic pancreatic cancer. Clinical hallmark features of pancreatic ductal…”
Get more information

Electron Transfer-Based Compounds: A Novel Weapon in the Cancer Battlespace? by Neesse, A., Hessmann, E.

Get full text

Therapeutic targeting of apoptotic pathways: novel aspects in pancreatic cancer by Neesse, A, Gress, T M, Michl, P

“…Pancreatic cancer constitutes one of the most aggressive tumours with a 5-year survival rate of less than 5%. It is characterized by a high degree of…”
Get more information

Prospective evaluation of duodenogastroesophageal reflux in gastroesophageal reflux disease patients refractory to proton pump inhibitor therapy by Kunsch, S, Neesse, A, Linhart, T, Nell, C, Gress, T M, Ellenrieder, V

“…Duodenogastroesophageal reflux (DGER) is considered an independent risk factor for complicated reflux disease (gastroesophageal reflux disease; GERD). However,…”
Get more information

Sperm-associated antigen 1 is expressed early in pancreatic tumorigenesis and promotes motility of cancer cells by NEESSE, A, GANGESWARAN, R, LUETTGES, J, FEAKINS, R, WEEKS, M. E, LEMOINE, N. R, CRNOGORAC-JURCEVIC, T

“…Sperm-associated antigen 1 (SPAG1) was recently identified in a rare form of infertility where anti-SPAG1 antibodies derived from the serum of an infertile…”
Get full text

Combined lung‐sound and reflux‐monitoring: a pilot study of a novel approach to detect nocturnal respiratory symptoms in gastro‐oesophageal reflux disease by Kunsch, S., Gross, V., Neesse, A., Sohrabi, K., Nell, C., Gress, T. M., Ellenrieder, V., Koehler, U.

“…Aliment Pharmacol Ther 2011; 33: 592–600 Summary Background  Increased prevalence of respiratory symptoms has been commonly reported in patients with…”
Get full text